China Aoxing Pharmaceutical Company Receives A New Injectable Drug Approval For Treating Ischemic Cerebrovascular Disease

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) (”China Aoxing”), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, Ltd.

More: continued here

Filed under: Stroke on January 3rd, 2009